imipramine has been researched along with Hypoglycemia in 5 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Six control subjects underwent an insulin tolerance test before and after the administration of therapeutic doses of imipramine hydrochloride for 10 days to investigate effects of tricyclic antidepressants on hypothalamic-pituitary-adrenal axis response to hypoglycemia." | 7.68 | Imipramine effect on hypothalamic-pituitary-adrenal axis response to hypoglycemia. ( Jaeckle, R; Kathol, RG; Sherman, BM; Wysham, C, 1992) |
| "Six control subjects underwent an insulin tolerance test before and after the administration of therapeutic doses of imipramine hydrochloride for 10 days to investigate effects of tricyclic antidepressants on hypothalamic-pituitary-adrenal axis response to hypoglycemia." | 3.68 | Imipramine effect on hypothalamic-pituitary-adrenal axis response to hypoglycemia. ( Jaeckle, R; Kathol, RG; Sherman, BM; Wysham, C, 1992) |
| "Narcolepsy may affect as many as 200,000 Americans." | 1.26 | Narcolepsy. Diagnosis and treatment. ( Carskadon, MA; Dement, WC; Guilleminault, C; Zarcone, VP, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kho, AR | 1 |
| Choi, BY | 1 |
| Lee, SH | 2 |
| Hong, DK | 1 |
| Kang, BS | 1 |
| Suh, SW | 1 |
| Shrivastava, RK | 1 |
| Edwards, D | 1 |
| Dement, WC | 1 |
| Carskadon, MA | 1 |
| Guilleminault, C | 1 |
| Zarcone, VP | 1 |
| Kathol, RG | 1 |
| Jaeckle, R | 1 |
| Wysham, C | 1 |
| Sherman, BM | 1 |
| Cryer, PE | 1 |
| Daughaday, WH | 1 |
5 other studies available for imipramine and Hypoglycemia
| Article | Year |
|---|---|
Administration of an Acidic Sphingomyelinase (ASMase) Inhibitor, Imipramine, Reduces Hypoglycemia-Induced Hippocampal Neuronal Death.
Topics: Ceramides; Hippocampus; Humans; Hypoglycemia; Imipramine; Sphingomyelin Phosphodiesterase | 2022 |
Hypoglycemia associated with imipramine.
Topics: Humans; Hypoglycemia; Imipramine; Male; Middle Aged | 1983 |
Narcolepsy. Diagnosis and treatment.
Topics: Adolescent; Adult; Behavior; Cataplexy; Child; Diagnosis, Differential; Female; Humans; Hypoglycemia | 1976 |
Imipramine effect on hypothalamic-pituitary-adrenal axis response to hypoglycemia.
Topics: Adrenocorticotropic Hormone; Adult; Blood Glucose; Female; Humans; Hydrocortisone; Hypoglycemia; Hyp | 1992 |
Regulation of growth hormone secretion in acromegaly.
Topics: Acromegaly; Adult; Arginine; Female; Glucose Tolerance Test; Growth Hormone; Humans; Hydrocortisone; | 1969 |